This paper evaluated [18F]AlF-PSMA-11 PET for expression-based imaging of prostate cancer and the effect of the amount of carrier administered on tumor uptake and tumor-to-organ ratios. This evidence concerns the gene FOLH1 and prostate carcinoma.